These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 37067924)

  • 1. Australian recommendations on perioperative use of disease-modifying anti-rheumatic drugs in people with inflammatory arthritis undergoing elective surgery.
    Buchbinder R; Glennon V; Johnston RV; Brennan SE; Fong C; Edward May S; O'Neill S; Smitham P; Trevena L; Whittaker G; Wluka A; Whittle SL
    Intern Med J; 2023 Jul; 53(7):1248-1255. PubMed ID: 37067924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Australian recommendations on tapering of biologic and targeted synthetic disease-modifying anti-rheumatic drugs in inflammatory arthritis.
    Whittle SL; Glennon V; Johnston RV; Avery JC; Bell JS; Brennan SE; Fong C; Hissaria P; Horgan B; O'Neill S; Pisaniello HL; Trevena L; Whittaker GA; Wluka A; Buchbinder R
    Intern Med J; 2022 Oct; 52(10):1799-1805. PubMed ID: 35567366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perioperative management of disease-modifying antirheumatic drugs for patients undergoing elective spine surgery: a systematic review.
    Mamaril-Davis JC; Aguilar-Salinas P; Avila MJ; Villatoro-Villar M; Dumont TM
    Eur Spine J; 2022 Apr; 31(4):815-829. PubMed ID: 35132461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perioperative Management of Antirheumatic Medications in Patients with RA and SLE Undergoing Elective Foot and Ankle Surgery: A Critical Analysis Review.
    Saunders NE; Holmes JR; Walton DM; Talusan PG
    JBJS Rev; 2021 Jun; 9(6):. PubMed ID: 34101706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2022 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty.
    Goodman SM; Springer BD; Chen AF; Davis M; Fernandez DR; Figgie M; Finlayson H; George MD; Giles JT; Gililland J; Klatt B; MacKenzie R; Michaud K; Miller A; Russell L; Sah A; Abdel MP; Johnson B; Mandl LA; Sculco P; Turgunbaev M; Turner AS; Yates A; Singh JA
    Arthritis Rheumatol; 2022 Sep; 74(9):1464-1473. PubMed ID: 35722708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2017 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty.
    Goodman SM; Springer B; Guyatt G; Abdel MP; Dasa V; George M; Gewurz-Singer O; Giles JT; Johnson B; Lee S; Mandl LA; Mont MA; Sculco P; Sporer S; Stryker L; Turgunbaev M; Brause B; Chen AF; Gililland J; Goodman M; Hurley-Rosenblatt A; Kirou K; Losina E; MacKenzie R; Michaud K; Mikuls T; Russell L; Sah A; Miller AS; Singh JA; Yates A
    Arthritis Rheumatol; 2017 Aug; 69(8):1538-1551. PubMed ID: 28620948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2017 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty.
    Goodman SM; Springer B; Guyatt G; Abdel MP; Dasa V; George M; Gewurz-Singer O; Giles JT; Johnson B; Lee S; Mandl LA; Mont MA; Sculco P; Sporer S; Stryker L; Turgunbaev M; Brause B; Chen AF; Gililland J; Goodman M; Hurley-Rosenblatt A; Kirou K; Losina E; MacKenzie R; Michaud K; Mikuls T; Russell L; Sah A; Miller AS; Singh JA; Yates A
    J Arthroplasty; 2017 Sep; 32(9):2628-2638. PubMed ID: 28629905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2022 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty.
    Goodman SM; Springer BD; Chen AF; Davis M; Fernandez DR; Figgie M; Finlayson H; George MD; Giles JT; Gilliland J; Klatt B; MacKenzie R; Michaud K; Miller A; Russell L; Sah A; Abdel MP; Johnson B; Mandl LA; Sculco P; Turgunbaev M; Turner AS; Yates A; Singh JA
    J Arthroplasty; 2022 Sep; 37(9):1676-1683. PubMed ID: 35732511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2017 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty.
    Goodman SM; Springer B; Guyatt G; Abdel MP; Dasa V; George M; Gewurz-Singer O; Giles JT; Johnson B; Lee S; Mandl LA; Mont MA; Sculco P; Sporer S; Stryker L; Turgunbaev M; Brause B; Chen AF; Gililland J; Goodman M; Hurley-Rosenblatt A; Kirou K; Losina E; MacKenzie R; Michaud K; Mikuls T; Russell L; Sah A; Miller AS; Singh JA; Yates A
    Arthritis Care Res (Hoboken); 2017 Aug; 69(8):1111-1124. PubMed ID: 28620917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2022 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty.
    Goodman SM; Springer BD; Chen AF; Davis M; Fernandez DR; Figgie M; Finlayson H; George MD; Giles JT; Gilliland J; Klatt B; MacKenzie R; Michaud K; Miller A; Russell L; Sah A; Abdel MP; Johnson B; Mandl LA; Sculco P; Turgunbaev M; Turner AS; Yates A; Singh JA
    Arthritis Care Res (Hoboken); 2022 Sep; 74(9):1399-1408. PubMed ID: 35718887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patients with rheumatoid arthritis undergoing surgery: how should we deal with antirheumatic treatment?
    Pieringer H; Stuby U; Biesenbach G
    Semin Arthritis Rheum; 2007 Apr; 36(5):278-86. PubMed ID: 17204310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors influencing clinician prescribing of disease-modifying anti-rheumatic drugs for inflammatory arthritis: A systematic review and thematic synthesis of qualitative studies.
    Lalor AF; Brooker JE; Rozbroj T; Whittle SL; Hill CL; Rowett D; Buchbinder R; O'Connor DA
    Semin Arthritis Rheum; 2022 Aug; 55():151988. PubMed ID: 35286905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perioperative management of disease-modifying antirheumatic drugs and other immunomodulators.
    Moreira PM; Correia AM; Cerqueira M; Gil MF
    ARP Rheumatol; 2022 Oct; 1(ARP Rheumatology, nº3 2022):218-224. PubMed ID: 36057090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Management of Perioperative Immunosuppressant Medications for Rheumatoid Arthritis During Elective Hand Surgery.
    Klifto KM; Cho BH; Lifchez SD
    J Hand Surg Am; 2020 Aug; 45(8):779.e1-779.e6. PubMed ID: 32209269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Better clinical outcome of total knee arthroplasty for rheumatoid arthritis with perioperative glucocorticoids and disease-modifying anti-rheumatic drugs after an average of 11.4-year follow-up.
    Ren Y; Yang Q; Luo T; Lin J; Jin J; Qian W; Weng X; Feng B
    J Orthop Surg Res; 2021 Jan; 16(1):84. PubMed ID: 33504345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-utility analysis of biologic disease-modifying antirheumatic drugs (bDMARDs), targeted synthetic DMARDs (tsDMARDs) and biosimilar DMARDs (bsDMARDs) combined with methotrexate for Thai rheumatoid arthritis patients with high disease activity.
    Prawjaeng J; Leelahavarong P; Budtarad N; Pilasant S; Chanjam C; Katchamart W; Narongroeknawin P; Kitumnuaypong T
    BMC Health Serv Res; 2023 May; 23(1):561. PubMed ID: 37259090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Impact of Perioperative Use of Nonbiologic Disease-Modifying Anti-rheumatic Drugs on Perioperative Blood Loss and Complications in Patients Who Have Rheumatoid Arthritis Undergoing Total Knee Arthroplasty.
    Jiang W; Jiang X; Xu H; Liu H; Huang Q; Huang Z; Zhou Z; Pei F
    J Arthroplasty; 2023 Aug; 38(8):1477-1483. PubMed ID: 36764400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of pharmacological treatment in rheumatoid arthritis: a systematic literature research informing the 2019 update of the EULAR recommendations for management of rheumatoid arthritis.
    Kerschbaumer A; Sepriano A; Smolen JS; van der Heijde D; Dougados M; van Vollenhoven R; McInnes IB; Bijlsma JWJ; Burmester GR; de Wit M; Falzon L; Landewé R
    Ann Rheum Dis; 2020 Jun; 79(6):744-759. PubMed ID: 32033937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2016 updated Thai Rheumatism Association Recommendations for the use of biologic and targeted synthetic disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis.
    Louthrenoo W; Kasitanon N; Katchamart W; Aiewruengsurat D; Chevaisrakul P; Chiowchanwisawakit P; Dechanuwong P; Hanvivadhanakul P; Mahakkanukrauh A; Manavathongchai S; Muangchan C; Narongroeknawin P; Phumethum V; Siripaitoon B; Suesuwan A; Suwannaroj S; Uea-Areewongsa P; Ukritchon S; Asavatanabodee P; Koolvisoot A; Nanagara R; Totemchokchyakarn K; Nuntirooj K; Kitumnuaypong T
    Int J Rheum Dis; 2017 Sep; 20(9):1166-1184. PubMed ID: 28730640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Economic Burden and Treatment Patterns of Cycling between Conventional Synthetic Disease-modifying Antirheumatic Drugs Among Biologic-treated Patients with Rheumatoid Arthritis.
    Betts KA; Griffith J; Ganguli A; Li N; Douglas K; Wu EQ
    Clin Ther; 2016 May; 38(5):1205-16. PubMed ID: 27045991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.